A drug developed for diabetes could be used to treat Alzheimer’s after scientists found it ‘significantly reversed memory loss’ in mice through a triple method of action. This is the first time that a triple receptor drug has been used which acts in multiple ways to protect the brain from degeneration. It combines three growth factors. Problems with growth factor signalling have been shown to be impaired in the brains of Alzheimer’s patients.